Kockaya, G. Et Al. 2019. COST EFFECTIVENESS OF RIVAROXABAN IN CORONARY ARTERY DISEASE AND/OR PERIPHERAL ARTERY DISEASE FOR 5 DIFFEREN PATIENT SUB-GROUPS IN TURKEY. VALUE IN HEALTH , vol.22 .

Kockaya, G., Ergin, O. G., Caliskan, Z., Okcun, S., Kurnaz, M., Buyuktuna, N., ... Buyukisik, T.(2019). COST EFFECTIVENESS OF RIVAROXABAN IN CORONARY ARTERY DISEASE AND/OR PERIPHERAL ARTERY DISEASE FOR 5 DIFFEREN PATIENT SUB-GROUPS IN TURKEY. VALUE IN HEALTH , vol.22.

Kockaya, G. Et Al. "COST EFFECTIVENESS OF RIVAROXABAN IN CORONARY ARTERY DISEASE AND/OR PERIPHERAL ARTERY DISEASE FOR 5 DIFFEREN PATIENT SUB-GROUPS IN TURKEY," VALUE IN HEALTH , vol.22, 2019

Kockaya, G. Et Al. "COST EFFECTIVENESS OF RIVAROXABAN IN CORONARY ARTERY DISEASE AND/OR PERIPHERAL ARTERY DISEASE FOR 5 DIFFEREN PATIENT SUB-GROUPS IN TURKEY." VALUE IN HEALTH , vol.22, 2019

Kockaya, G. Et Al. (2019) . "COST EFFECTIVENESS OF RIVAROXABAN IN CORONARY ARTERY DISEASE AND/OR PERIPHERAL ARTERY DISEASE FOR 5 DIFFEREN PATIENT SUB-GROUPS IN TURKEY." VALUE IN HEALTH , vol.22.

@article{article, author={G. Kockaya Et Al. }, title={COST EFFECTIVENESS OF RIVAROXABAN IN CORONARY ARTERY DISEASE AND/OR PERIPHERAL ARTERY DISEASE FOR 5 DIFFEREN PATIENT SUB-GROUPS IN TURKEY}, journal={VALUE IN HEALTH}, year=2019}